IPCS INCHEM Home

International Agency for Research on Cancer (IARC) - Summaries & Evaluations

b-BUTYROLACTONE
(Group 2B)

For definition of Groups, see Preamble Evaluation.

VOL.: 71 (1999) (p. 1317)

CAS No.: 3068-88-0

5. Evaluation

No epidemiological data relevant to the carcinogenicity of b-butyrolactone were available.

There is sufficient evidence in experimental animals for the carcinogenicity of b-butyrolactone.

Overall evaluation

b-Butyrolactone is possibly carcinogenic to humans (Group 2B).

For definition of the italicized terms, see Preamble Evaluation.

Previous evaluation: Vol. 11 (1976)

Synonym


Last updated: 13 April 1999





















    See Also:
       Toxicological Abbreviations
       Butyrolactone, beta-  (IARC Summary & Evaluation, Volume 11, 1976)